# GLAUKOS Corp: filings

GKOS · NYSE · CIK 1192448 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gkos.md) · [Financials](/companies/gkos/financials.md) · [Filings](/companies/gkos/filings.md) · [Insiders](/companies/gkos/insiders.md)

## Reports and events: 208 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 520, 8-K 143, 144 111, SC 13G/A 56, 10-Q 35, 3 31, SC 13G 25, 4/A 16, 10-K 11, DEF 14A 11, S-8 11, DEFA14A 10, 425 9, SD 9, CORRESP 8, SCHEDULE 13G/A 6, UPLOAD 6, D 5, SCHEDULE 13G 5, 5 4, ARS 4, 8-K/A 3, DRS/A 3, S-1/A 3, DRSLTR 2, EFFECT 2, S-8 POS 2, 424B3 1, 424B4 1, 8-A12B 1, CERTNYS 1, DRS 1, S-1 1, S-4 1, S-4/A 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-28 | 17:22 ET | [10-Q](/filings/0001193125-26-436400.md) | Quarterly report, period 2026-09-30 | 0001193125-26-436400 |
| 2026-10-28 | 16:10 ET | [8-K](/filings/0001193125-26-436147.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-436147 |
| 2026-08-03 | 07:00 ET | [8-K](/filings/0001192448-26-000002.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001192448-26-000002 |
| 2026-07-29 | 17:06 ET | [10-Q](/filings/0001193125-26-324201.md) | Quarterly report, period 2026-06-30 | 0001193125-26-324201 |
| 2026-07-29 | 16:10 ET | [8-K](/filings/0001193125-26-323729.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-323729 |
| 2026-06-03 | 17:12 ET | [8-K](/filings/0001193125-26-255758.md) | 5.07 Shareholder vote results | 0001193125-26-255758 |
| 2026-05-04 | 07:00 ET | [8-K](/filings/0001193125-26-202466.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-202466 |
| 2026-04-30 | 19:30 ET | [10-Q](/filings/0001193125-26-193004.md) | Quarterly report, period 2026-03-31 | 0001193125-26-193004 |
| 2026-04-29 | 16:10 ET | [8-K](/filings/0001193125-26-191553.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-191553 |
| 2026-04-16 | 06:01 ET | [DEF 14A](/filings/0001193125-26-157829.md) | Proxy statement, period 2026-05-28 | 0001193125-26-157829 |
| 2026-03-02 | 07:00 ET | [8-K](/filings/0001104659-26-021885.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-021885 |
| 2026-02-23 | 19:54 ET | [10-K](/filings/0001193125-26-061944.md) | Annual report, period 2025-12-31 | 0001193125-26-061944 |
| 2026-02-17 | 16:10 ET | [8-K](/filings/0001104659-26-016410.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-016410 |
| 2026-01-13 | 16:05 ET | [8-K](/filings/0001104659-26-003321.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-003321 |
| 2025-11-10 | 07:00 ET | [8-K](/filings/0001104659-25-108796.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-108796 |
| 2025-10-31 | 18:53 ET | [10-Q](/filings/0001104659-25-104529.md) | Quarterly report, period 2025-09-30 | 0001104659-25-104529 |
| 2025-10-29 | 16:10 ET | [8-K](/filings/0001104659-25-103722.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-103722 |
| 2025-08-12 | 07:00 ET | [8-K](/filings/0001558370-25-011142.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-011142 |
| 2025-08-04 | 16:56 ET | [10-Q](/filings/0001558370-25-010113.md) | Quarterly report, period 2025-06-30 | 0001558370-25-010113 |
| 2025-07-30 | 16:10 ET | [8-K](/filings/0001558370-25-009798.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-009798 |
| 2025-06-03 | 16:23 ET | [8-K](/filings/0001558370-25-008365.md) | 5.07 Shareholder vote results | 0001558370-25-008365 |
| 2025-05-14 | 07:00 ET | [8-K](/filings/0001558370-25-007647.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-007647 |
| 2025-05-01 | 06:02 ET | [10-Q](/filings/0001558370-25-006041.md) | Quarterly report, period 2025-03-31 | 0001558370-25-006041 |
| 2025-04-30 | 16:10 ET | [8-K](/filings/0001558370-25-005999.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-005999 |
| 2025-04-15 | 16:30 ET | [DEF 14A](/filings/0001558370-25-004839.md) | Proxy statement, period 2025-05-29 | 0001558370-25-004839 |
| 2025-03-12 | 07:00 ET | [8-K](/filings/0001558370-25-002745.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-002745 |
| 2025-02-25 | 18:11 ET | [10-K](/filings/0001558370-25-001402.md) | Annual report, period 2024-12-31 | 0001558370-25-001402 |
| 2025-02-20 | 16:10 ET | [8-K](/filings/0001558370-25-001217.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-001217 |
| 2025-01-14 | 16:05 ET | [8-K](/filings/0001558370-25-000201.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-000201 |
| 2024-12-09 | 06:30 ET | [8-K](/filings/0001558370-24-016082.md) | 7.01 Regulation FD disclosure | 0001558370-24-016082 |
| 2024-12-03 | 06:02 ET | [8-K](/filings/0001558370-24-015973.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001558370-24-015973 |
| 2024-11-15 | 07:00 ET | [8-K](/filings/0001558370-24-015776.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-015776 |
| 2024-11-05 | 17:49 ET | [10-Q](/filings/0001558370-24-014295.md) | Quarterly report, period 2024-09-30 | 0001558370-24-014295 |
| 2024-11-04 | 16:10 ET | [8-K](/filings/0001558370-24-014262.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-014262 |
| 2024-10-11 | 17:27 ET | [8-K](/filings/0001558370-24-013262.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-013262 |
| 2024-08-09 | 07:00 ET | [8-K](/filings/0001558370-24-011675.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-011675 |
| 2024-08-02 | 16:51 ET | [8-K/A](/filings/0001558370-24-010731.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-010731 |
| 2024-08-02 | 16:44 ET | [10-Q](/filings/0001558370-24-010729.md) | Quarterly report, period 2024-06-30 | 0001558370-24-010729 |
| 2024-07-31 | 16:10 ET | [8-K](/filings/0001558370-24-010478.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-010478 |
| 2024-06-28 | 16:47 ET | [8-K](/filings/0001104659-24-076328.md) | 3.02 Unregistered sale of equity; 8.01 Other events | 0001104659-24-076328 |
| 2024-06-14 | 07:10 ET | [8-K](/filings/0001558370-24-009169.md) | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-24-009169 |
| 2024-06-05 | 07:01 ET | [8-K](/filings/0001558370-24-008913.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001558370-24-008913 |
| 2024-05-20 | 07:00 ET | [8-K](/filings/0001558370-24-008440.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-008440 |
| 2024-05-03 | 17:38 ET | [10-Q](/filings/0001558370-24-006573.md) | Quarterly report, period 2024-03-31 | 0001558370-24-006573 |
| 2024-05-01 | 16:10 ET | [8-K](/filings/0001558370-24-006383.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-006383 |
| 2024-04-16 | 17:00 ET | [DEF 14A](/filings/0001558370-24-005203.md) | Proxy statement, period 2024-05-30 | 0001558370-24-005203 |
| 2024-02-28 | 07:00 ET | [8-K](/filings/0001558370-24-001912.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-001912 |
| 2024-02-23 | 17:23 ET | [10-K](/filings/0001558370-24-001630.md) | Annual report, period 2023-12-31 | 0001558370-24-001630 |
| 2024-02-21 | 16:10 ET | [8-K](/filings/0001558370-24-001431.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-001431 |
| 2024-01-09 | 07:00 ET | [8-K](/filings/0001558370-24-000141.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-000141 |

Page 1 of 5. [Older](/companies/gkos/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 13:05 ET. No prices; not investment advice.